N.B. reports first case of blood-clotting from AstraZeneca vaccine; no new cases of COVID-19 – CTV
April 20, 2021
HALIFAX — New Brunswick reported its first case of blood-clotting in a person who received the Oxford-AstraZeneca COVID-19 vaccine.
Dr. Jennifer Russell, the province’s chief medical officer of health, said the person is in their 30s and received the vaccine in mid-March, before the National Advisory Committee on Immunization (NACI) recommendation on March 29 to not give it to anyone younger than 55.
“While every adverse reaction is unfortunate, it is important to remember that these blood clots are extremely rare,” Russell said. “The vaccine helps prevent the much higher risks associated with COVID-19 infections.”
Russell said that the global frequency of VITT is low and has been estimated at about one case in 100,000 to 250,000 doses of vaccine.
The person suffered the adverse reaction in the expected range of five to 21 days after getting the shot.
